health
STAT+: Cambrian’s experimental longevity drug mimics exercise
Why this matters: health reporting relevant to everyday decisions and well-being.
Want to stay on top of the science and politics driving biotech today?&#x A0;Sign up&#x A0;to get our biotech newsletter in your inbox. Washington’s vaccine wars are escalating again as Senate Democrats seek to build a paper trail around Health Secretary Robert F. Kennedy Jr.’s controversial overhaul of the CDC’s vaccine advisory committee. Also, Enanta’s pushing forward with its RSV antiviral, we take a critical look at Patrick Soon-Shiong’s pancreatic cancer claims, and some news from longevity player Cambria.Continue to STAT+ to read the full story…
Article preview — originally published by STAT News. Full story at the source.
Read full story on STAT News →
More top stories
Aggregated and edited by the Scoop newsroom. We surface news from STAT News alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop